FcRn Therapies 2021 Conference: Humanized Mouse Models to Assess the In Vivo Efficacy of Antibody Therapeutics

FcRn Therapies 2021 Conference: Humanized Mouse Models to Assess the In Vivo Efficacy of Antibody Therapeutics

Speaker: Jenna Frame, PhD, Senior Scientist, Scientific Communications

    • Humanized mouse models serve as powerful preclinical models to evaluate the in vivo efficacy of anti-human antibody candidates
    • Biocytogen’s humanized IL4/IL4RA mice have been used to validate antibody drugs targeting IL4 signaling in the context of experimentally-induced asthma and atopic dermatitis
    • Humanized IL-17 mice are a validated tool to assess anti-human IL-17 therapies and can be used as a model for experimentally-induced psoriasis

Share:

Please fill out the form below to request a download of this Webinar